The short answer
Kenvue is HALAL in ZakatInvest's qualitative activity classification, with an INCOMPLETE overall screen pending a prohibited-revenue numerator. Its disclosed debt, liquidity, receivables and interest-income ratios are below the examined asset-based limits.
This is a reproducible research screen, not a fatwa or investment recommendation. Readers should apply their school's principles and consult a qualified scholar for a binding ruling.
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-29; calculated 2026-07-13.
8,661 / 26,854
1,075 / 26,854
3,576 / 26,854
11 / 3,909
- Financial
- Pass
- Overall
- Incomplete
Debt is 32.25%, liquidity is 4.00%, receivables plus cash are 13.32% and disclosed interest income is 0.28%, below the examined FTSE limits. The business screen remains incomplete without a prohibited-revenue numerator.
- Financial
- Pass
- Overall
- Incomplete
Debt is 32.25%, liquidity is 4.00% and receivables plus cash are 13.32%, below the examined MSCI total-assets limits. The business screen remains incomplete because no universal prohibited-revenue numerator is disclosed.
- Financial
- Pass
- Overall
- Incomplete
Debt is 32.25% and liquidity is 4.00%, below the examined Malaysia SAC financial limits. The business screen remains incomplete because no universal prohibited-revenue numerator is disclosed.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible historical market-cap series is not stored, so these methods are not estimated from a current spot price.
Business-activity disclosure
Kenvue is a consumer-health company with personal-care, over-the-counter medicines, skin health, beauty and essential-health brands. Consumer healthcare and personal-care products are generally permissible at the activity level.
Limitation: The filing does not allocate a universal prohibited-revenue numerator by ingredient, product certification, customer use or brand; no exact prohibited-revenue percentage is asserted.
Purification
Kenvue discloses interest income but does not prescribe a scholar-approved purification percentage. Readers should follow the qualified scholar or methodology they use rather than applying an invented fixed rate.
Inputs, assumptions and primary sources
- Inputs use Kenvue's March 29, 2026 Form 10-Q; amounts are USD millions and revenue and interest income are for the fiscal three months.
- Debt uses total reported debt of $8,661 million: loans and notes payable of $1,589 million plus long-term debt of $7,072 million.
- Cash uses $1,075 million of cash and cash equivalents. No separate securities balance is used.
- Receivables use $2,501 million of trade receivables, excluding prepaid expenses and other receivables.
- Quarterly net sales are $3,909 million and disclosed interest income is $11 million; the screen does not infer a fixed purification rate.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Current quantitative screen
The calculations use Kenvue's official filing at the SEC (first-quarter 2026 Form 10-Q). Amounts are in USD millions and revenue and interest income are for the fiscal quarter.
- Interest-bearing debt / assets: 32.25%, using $1,589 million of loans and notes payable plus $7,072 million of long-term debt.
- Cash / assets: 4.00%, using $1,075 million of cash and cash equivalents.
- Receivables plus cash / assets: 13.32%, using $2,501 million of trade receivables plus cash.
- Disclosed interest income / revenue: 0.28%, using $11 million of interest income and $3,909 million of net sales.
The examined financial ratios are below the named asset-based limits. Market-cap denominator methods are not calculated because ZakatInvest does not store a licensed, reproducible historical market-cap series.
Kenvue's business activity
Kenvue is a consumer-health company with personal-care, over-the-counter medicines, skin health and beauty brands. Consumer healthcare and personal-care products are generally permissible at the activity level. The filing does not provide a universal prohibited-revenue numerator by ingredient, certification, brand or customer use, so the business-activity field remains incomplete.
Qualitative considerations
- Product liability: acetaminophen, talc and other product-liability and regulatory matters require ongoing legal and safety diligence.
- Consumer-health ethics: ingredient sourcing, testing, marketing claims, product access and environmental impacts remain broader ethical topics.
- Pending transaction: the proposed Kimberly-Clark transaction could materially change Kenvue's corporate perimeter and product mix if completed.
- Purification: Kenvue discloses interest income but does not prescribe a scholar-approved fixed purification percentage.
Verdict
KVUE is HALAL in ZakatInvest's qualitative classification, with an INCOMPLETE overall screen because no universal prohibited-revenue percentage is disclosed. Revisit this record when Kenvue files new statements or materially changes its portfolio, litigation, capital structure or pending transaction.
Use the quantitative screen alongside your school's principles and consult a qualified scholar before investing.
Find halal alternatives →